MedPath

Impact of Maltodextrin on Glycemic and Hemodynamic Management During Cesarean Section

Not Applicable
Active, not recruiting
Conditions
Cesarean Section Complications
Registration Number
NCT05553756
Lead Sponsor
University of Foggia
Brief Summary

The goal is to evaluate the glycemic and hemodynamic stability in patients undergoing caesarean section in patients treated with maltodextrins two hours before the cesarean section

Detailed Description

The patients undergoing elective cesarean section will be randomly divided in two groups: patients who drink 200 ml of clear liquid two hours before surgery or patients treated with 200 ml maltodextrins two hours before the surgery. The glycemic control will be done immediately before the maldodextrin administration and after the cesarean section by gluco stick. Standard hemodynamic monitoring ECG, Heart Rate, Blood pressure, Temperature, preipheral oxygen saturation will be done routinely.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • informed consent
  • first cesarean section
  • single fetus
  • ASA I-II
Exclusion Criteria
  • BMI<18
  • BMI>35
  • contraindication to spinal anesthesia
  • cardiovascular diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Glycemic stabilityperioperative

blood glucose levels \<180 mg/dl

hemodynamic stabilityperioperative

mean arterial pressure \> 70 mmHg during perioperative time

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Foggia

🇮🇹

Foggia, Italy

University of Foggia
🇮🇹Foggia, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.